KORU Medical Systems, Inc. recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating changes in ownership of company shares by insiders or affiliates. This filing is significant as it provides transparency regarding any buying or selling of company stock by individuals with access to non-public information. Investors and analysts often monitor such filings to gauge the confidence levels of insiders in the company’s future performance.
KORU Medical Systems, Inc. is a company that specializes in the development and commercialization of innovative medical devices for the treatment of respiratory conditions. Their products aim to improve the quality of life for patients suffering from chronic respiratory diseases. For more information about KORU Medical Systems, Inc., you can visit their website here.
Form 4 is a document filed with the SEC to disclose any changes in ownership of company securities, such as stocks or options, by directors, officers, or beneficial owners. This filing is required under Section 16 of the Securities Exchange Act of 1934 to ensure transparency and prevent insider trading. Investors rely on Form 4 filings to track the buying and selling activities of company insiders, which can provide insights into the company’s financial health and future prospects.
Read More:
KORU Medical Systems, Inc. SEC Filing: What You Need to Know
Leave a Reply